1. Home
  2. AVIR vs SWMR Comparison

AVIR vs SWMR Comparison

Compare AVIR & SWMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$4.89

Market Cap

434.5M

Sector

Health Care

ML Signal

HOLD

SWMR

Swarmer Inc Common Stock

N/A

Current Price

$39.70

Market Cap

453.1M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
AVIR
SWMR
Founded
2012
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
434.5M
453.1M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
AVIR
SWMR
Price
$4.89
$39.70
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
330.7K
458.1K
Earning Date
05-11-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
3.00
N/A
EPS
N/A
N/A
Revenue
$351,367,000.00
N/A
Revenue This Year
N/A
$2,862.05
Revenue Next Year
N/A
$177.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.78
$25.75
52 Week High
$6.45
$83.30

Technical Indicators

Market Signals
Indicator
AVIR
SWMR
Relative Strength Index (RSI) 60.79 45.18
Support Level $4.14 $35.08
Resistance Level $6.37 $52.10
Average True Range (ATR) 0.21 5.13
MACD 0.08 -0.61
Stochastic Oscillator 82.72 27.02

Price Performance

Historical Comparison
AVIR
SWMR

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

About SWMR Swarmer Inc Common Stock

Swarmer Inc is a provider of autonomous drone swarm software and AI solutions, specializing in vendor-agnostic technologies. It develops software platforms and artificial intelligence systems for defence applications, enabling military organisations to deploy and coordinate large-scale unmanned and autonomous systems. Its offerings include swarm coordination software, multi-domain unmanned systems integration, collaborative autonomy solutions, and command-and-control software for distributed robotic operations. Its key software and AI systems include: i) STYX AI Command & Control System, ii) MINAS Autonomy and Collaboration AI and iii) TRIDENT Embedded Drone Operating System. The company generates revenue through software license sales.

Share on Social Networks: